This might be a population of patients that would
Post# of 148165
(Total Views: 438)
Posted On: 01/15/2021 9:20:16 AM
This might be a population of patients that would benefit from Generex Biotechnolgy's "Complete Vaccine" that should be about to start trials. Unfortunately that means they are a way off from bringing it to market.
BTW, I emaled Dr Pourhassan, GNBT's recent trademark action about the vaccine as a potential concept for CYDY. Leronlimab has so many applications it would be fitting to have a marketing tag.
BTW, I emaled Dr Pourhassan, GNBT's recent trademark action about the vaccine as a potential concept for CYDY. Leronlimab has so many applications it would be fitting to have a marketing tag.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼